Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014


SMi ADMET 2014

30 Jun 2014 - 01 Jul 2014 - London, UK



Bookmark and Share


SMi presents the 9th annual conference on: ADMET

Enhancing drug quality by ADMET optimisation in discovery

SMi’s established ADMET conference has been a premier event in its field for almost a decade. The 9th annual event taking place on 30th June and 1st July in central London, will bring together even more industry leading experts to deliver over eighteen case study driven presentations. A focal point for anyone working in the market for drug discovery and development, attending provides a unique forum to engage with KOL’s and experts active in the field.

ADMET 2014 will enable delegates to gain valuable insights into enhancing drug quality by ADMET optimisation in discovery. It will focus on themes including Predictive ADME, Screening Approaches, Predictive Toxicology, Drug to Drug interactions and emerging issues such as regulatory changes. Click here for the agenda  

 Previous events in the ADMET series have received positive feedback from the industry including, 

"Excellent" – Pharmidex, "Nice mix of attendees" – Grunenthal, "Good conference at general level to update your current knowledge" - Orion Corporation and "Great conference…well organised" - Sanofi

Key Speakers Include:

  • Natalie Gobeau, Metabolism and Pharmacokinetics, Novartis
  • Dietmar-Weitz, Lab Head/ADME In Vitro Systems, Sanofi-Aventis
  • Sarah Baldwin, In Vitro DMPK Manager, GSK
  • Chris Powell, VP Safety Assessment, GSK
  • Georg Schmitt, Head of Toxicology, Roche Pharmaceuticals
  • Richard Thompson, Principal Scientist, AstraZeneca
  • Franck Atienzar, Associate Director, In Vitro and In Silico Toxicology, UCB
  • Adina Tocoian, Senior Clinical Pharmacologist, UCB
  • David Fairman, Senior Clinical Pharmacokinetist, MedImmune

Reasons to Attend:

  • Understand how to integrate ADME and toxicity data to enhance the prediction and understanding of drug safety in humans 
  • Hear the latest updates on drug transporters including the evolving transporter strategies in drug development and the different roles of drug transporters in R&D 
  • Explore the ADME properties of peptides in drug discovery 
  • Evaluate and overcome the challenges of making an accurate human dose prediction 

Registration is now live. Click here to secure your place today and save £300.

For further details and to book your place, visit: http://www.smi-online.co.uk/goto/2014admet8.asp

Alternatively contact the Team on +44 (0)20 7827 6000 or email events@smi-online.co.uk 



Further information
Scientific News
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Development in Preventing Macular Degeneration
Following macular degeneration insight, promising drugs to prevent vision loss have been identified.
Improving Tumour Therapy with Nanoparticles
UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.
New Antidepressant Treatment Discovered
Scientists have demonstrated how gene therapy could lead to new treatments for depression.
Cellular Origin of Skin Cancer Identified
Scientists have identified ‘cell of origin’ in the most common form of skin cancer, and followed the process that leads to tumour growth.
Enhancing Drug Safety with a Web-Based Data Tool
Online and open-access tool allows anyone to find, combine and analyse FDA drug information.
Genetic Missing Link Could Explain Mystery of Heritability
Mother’s diet during pregnancy can permanently affect offspring attributes through process that could be strongly influenced by genetic variation in an unexpected part of the genome.
Does the Transport of Next-Gen Vaccines Lie with E.coli?
Study shows harmless E.coli capsule could aid next-gen vaccine delivery and efficiency.
Breathing in a Cure
Researchers working on inhalable ibuprofen to treat cystic fibrosis.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!